LG / American Optical / Marrow Transplantation Group / Scheinberg LC / Brodsky / SF Health Outcomes Scoring Software / QualityMetric Inc / analyzed using SF Health Outcomes Scoring Software / /
Continent
Europe / /
Country
United States / / /
Event
Person Communication and Meetings / /
Facility
Stony Brook University / State University of New York / /
IndustryTerm
treatment of multiple sclerosis / ONLINE AUGUST / magnetic resonance imaging / brain magnetic resonance imaging / treatment of post Lyme disease / radiographic imaging / /
MedicalCondition
severe systemic lupus erythematosus / systemic lupus erythematosus / severe refractory myasthenia gravis / JE / absolute neutropenia / heart dysfunction / herpes zoster / neurologic disease / urinary infections / Severe Refractory Multiple Sclerosis Douglas E. Gladstone / refractory / severe autoimmune disease / nausea / such active disease / severe multiple sclerosis / clinical disease / asymptomatic cardiac dysfunction / active bronchitis / long-term disease / secondary progressive multiple sclerosis / febrile neutropenia / fatigue / multiple sclerosis / leukemias / documented herpes zoster infections / urinary tract infections / post Lyme disease / MS / Lupus / fixed neurologic deficits / Clinically significant heart failure / sepsis / autoimmune diseases / pneumonia / severe autoimmune diseases / disease / cohort’s disease / median disease / previously untreated severe aplastic anemia / Neutropenia / severe progressive multiple sclerosis / fever / vomiting / Pain / active disease / secondary progressive disease / severe refractory chronic inflammatory demyelinating polyneuropathy / immune-mediated polyneuropathies / common immune-mediated inflammatory and demyelinating disorder / treatment-refractory multiple sclerosis / infection / severe refractory multiple sclerosis / transient dilated cardiomyopathy / acute myeloid leukemia / Hemorrhagic cystitis / /
Stony Brook University Health Sciences Center / Food and Drug Administration / American Academy of Neurology / Stony Brook University / State University of New York / American Society of Hematology / MS Council for Clinical Practice Guidelines / American Medical Association / Therapeutics and Technology Assessment Subcommittee / /
Person
Ann Prestrud / ARCH NEUROL / Douglas E. Gladstone / Ann Neurol / Patricia K. Coyle / Robert Peyster / Lauren Krupp / Christopher Christodoulou / Kenneth W. Zamkoff / Ann Intern / Emily Locher / Patrick Sibony / / /
ORIGINAL CONTRIBUTION High-Dose Cyclophosphamide for Moderate to Severe Refractory Multiple Sclerosis Douglas E. Gladstone, MD; Kenneth W. Zamkoff, MD; Lauren Krupp, MD; Robert Peyster, MD; Patrick Sibony, MD; Christoph